Disease characteristics and management of hospitalised adolescents and adults with community-acquired pneumonia in China: a retrospective multicentre survey

被引:44
作者
Chen, Liang [1 ,2 ]
Zhou, Fei [1 ]
Li, Hui [3 ]
Xing, Xiqian [4 ]
Han, Xiudi [5 ]
Wang, Yiming [3 ]
Zhang, Chunxiao [6 ]
Suo, Lijun [7 ]
Wang, Jingxiang [8 ]
Yu, Guohua [9 ]
Wang, Guangqiang [10 ]
Yao, Xuexin [11 ]
Yu, Hongxia [12 ]
Wang, Lei [13 ]
Liu, Meng [1 ]
Xue, Chunxue [1 ]
Liu, Bo [7 ]
Zhu, Xiaoli [14 ]
Li, Yanli [1 ]
Xiao, Ying [1 ]
Cui, Xiaojing
Li, Lijuan
Uyeki, Timothy M. [15 ]
Wang, Chen [3 ,16 ]
Cao, Bin [3 ,16 ]
机构
[1] Capital Med Univ, Beijing Chao Yang Hosp, Dept Infect Dis & Clin Microbiol, Beijing, Peoples R China
[2] Peking Univ, Med Coll 4, Dept Infect Dis, Beijing Jishuitan Hosp, Beijing, Peoples R China
[3] China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Ctr Resp Dis, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China
[4] Kunming Med Univ, Yanan Hosp, Dept Resp Med, Kunming, Yunnan, Peoples R China
[5] Qingdao Municipal Hosp, Dept Resp Med, Qingdao, Peoples R China
[6] Beijing Huimin Hosp, Dept Resp Med, Beijing, Peoples R China
[7] Linzi Dist Peoples Hosp, Dept Resp Med, Zibo, Peoples R China
[8] Capital Med Univ, Beijing Luhe Hosp, Dept Resp Med, Weifang, Peoples R China
[9] Weifang 2 Peoples Hosp, Dept Pulm & Crit Care Med, Weifang, Peoples R China
[10] Shandong Univ Qindao, Dept Resp Med, Qilu Hosp, Qingdao, Peoples R China
[11] Chinese Armed Police Forces, Hosp Beijing Corps 2, Dept Resp Med, Beijing, Peoples R China
[12] Yantai Yuhuangding Hosp, Dept Infect Dis, Yantai, Peoples R China
[13] Shandong Chinese Med Univ, Rizhao Chinese Med Hosp, Dept Resp Med, Rizhao, Peoples R China
[14] Capital Med Univ, Beijing Chao Yang Hosp, Occupat Med & Toxicol Dept, Beijing, Peoples R China
[15] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA
[16] Capital Med Univ, Dept Pulm Med, Beijing, Peoples R China
来源
BMJ OPEN | 2018年 / 8卷 / 02期
关键词
LOW-RISK PATIENTS; MULTIDRUG-RESISTANT PATHOGENS; CARE-ASSOCIATED PNEUMONIA; ORAL ANTIBIOTICS; COST; TUBERCULOSIS; POPULATION; VALIDATION; MORTALITY; SEVERITY;
D O I
10.1136/bmjopen-2017-018709
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To describe the clinical characteristics and management of patients hospitalised with community-acquired pneumonia (CAP) in China. Design This was a multicentre, retrospective, observational study. Setting 13 teaching hospitals in northern, central and southern China from 1 January 2014 to 31 December 2014 Participants Information on hospitalised patients aged >= 14 years with radiographically confirmed pneumonia with illness onset in the community was collected using standard case report forms. Primary and secondary outcome measures Resource use for CAP management. Results Of 14 793 patients screened, 5828 with radiographically confirmed CAP were included in the final analysis. Low mortality risk patients with a CURB-65 score 0-1 and Pneumonia Severity Index risk class I-II accounted for 81.2% (4434/5594) and 56.4% (2034/3609) patients, respectively. 21.7% (1111/5130) patients had already achieved clinical stability on admission. A definite or probable pathogen was identified only in 12.7% (738/5828) patients. 40.9% (1575/3852) patients without pseudomonal infection risk factors received antimicrobial overtreatment regimens. The median duration between clinical stability to discharge was 5.0 days with 30-day mortality of 4.2%. Conclusions These data demonstrated the overuse of health resources in CAP management, indicating that there is potential for improvement and substantial savings to healthcare systems in China.
引用
收藏
页数:9
相关论文
共 41 条
  • [31] A prospective, multicenter study of a pneumonia practice guideline
    Rhew, DC
    Riedinger, MS
    Sandhu, M
    Bowers, C
    Greengold, N
    Weingarten, SR
    [J]. CHEST, 1998, 114 (01) : 115 - 119
  • [32] Incidence, direct costs and duration of hospitalization of patients hospitalized with community acquired pneumonia: A nationwide retrospective claims database analysis
    Rozenbaum, Mark H.
    Mangen, Marie-Josee J.
    Huijts, Susanne M.
    van der Werf, Tjip S.
    Postma, Maarten J.
    [J]. VACCINE, 2015, 33 (28) : 3193 - 3199
  • [33] MOXIFLOXACIN USE AND ITS ASSOCIATION ON THE DIAGNOSIS OF PULMONARY TUBERCULOSIS IN AN INNER CITY EMERGENCY DEPARTMENT
    Rush, Barret
    Wormsbecker, Andrew
    Stenstrom, Rob
    Kassen, Barry
    [J]. JOURNAL OF EMERGENCY MEDICINE, 2016, 50 (03) : 371 - 375
  • [34] Salo P, 1999, Semin Respir Infect, V14, P128
  • [35] Sayan Murat, 2003, Mikrobiyoloji Bulteni, V37, P247
  • [36] Healthcare-Associated Pneumonia among Hospitalized Patients: Is It Different from Community Acquired Pneumonia?
    Seong, Gil Myung
    Kim, Miok
    Lee, Jaechun
    Lee, Jong Hoo
    Jeong, Sun Young
    Choi, Yunsuk
    Kim, Woo Jeong
    [J]. TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 76 (02) : 66 - 74
  • [37] Validation of a Clinical Score for Assessing the Risk of Resistant Pathogens in Patients With Pneumonia Presenting to the Emergency Department
    Shorr, Andrew F.
    Zilberberg, Marya D.
    Reichley, Richard
    Kan, Jason
    Hoban, Alex
    Hoffman, Justin
    Micek, Scott T.
    Kollef, Marin H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 54 (02) : 193 - 198
  • [38] FDA and the safe and appropriate antibiotic use of fluoroquinolones
    Tillotson, Glenn S.
    [J]. LANCET INFECTIOUS DISEASES, 2016, 16 (03) : E11 - E12
  • [39] Development of a risk-adjusted in-hospital mortality prediction model for community-acquired pneumonia: a retrospective analysis using a Japanese administrative database
    Uematsu, Hironori
    Kunisawa, Susumu
    Sasaki, Noriko
    Ikai, Hiroshi
    Imanaka, Yuichi
    [J]. BMC PULMONARY MEDICINE, 2014, 14
  • [40] WOODHEAD MA, 1987, LANCET, V1, P671